Role of P<sub>2</sub> × <sub>7</sub> receptor during focused ultrasound induced blood brain barrier modulation.
Authors: Park J, Na YC, Lee J, Seo Y, Kim H, Han S, Song BW, Chang WS
Although low-intensity focused ultrasound (LiFUS) with microbubbles is used to temporally open the blood-brain barrier (BBB), the underlying mechanism is not fully understood. This study aimed to analyze BBB-related alterations in the brain microenvironment after LiFUS, with a focus on the involvement of the purinergic P<sub>2</sub> × <sub>7</sub> receptor. Sprague-Dawley rats were sonicated with LiFUS at 0.3 MPa energy. The impact of LiFUS on the P<sub>2</sub> × <sub>7</sub> receptor and inflammatory-related proteins, including NLRP3 and interleukin-1β, was analyzed through western blotting. The BBB-associated tight junction proteins, zonula occludens-1 (ZO-1) and occludin, were also analyzed. BBB permeability was assessed by quantifying the amount of Evans blue dye penetration using spectrophotometry. Furthermore, the safety of the sonication procedure was verified via terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay and hematoxylin and eosin staining. Substantial increases in the P<sub>2</sub> × <sub>7</sub> receptor and its downstream signaling were confirmed after sonicating the BBB with LiFUS for 1 h (p < 0.05). Conversely, for tight junction proteins, the lowest expression was observed at 1 h (p < 0.001). Both responses were normalized back to the original state over time. No evidence of brain damage was observed during the procedure. Furthermore, the P<sub>2</sub> × <sub>7</sub> receptor antagonist-injected group showed reduced Evans blue dye penetration compared to that 1 h after FUS, indicating a mitigated impact of LiFUS on the BBB. Herein, we elucidate the underlying mechanism by which LiFUS affects the BBB, with a focus on the involvement of the P<sub>2</sub> × <sub>7</sub> receptor. Our findings demonstrate that the extent of BBB opening varies upon the regulation of the P<sub>2</sub> × <sub>7</sub> receptor. This study provides valuable insights into the mechanisms underlying BBB modulation through LiFUS, thereby laying the foundation for expanding its applications.
Introduction
Purpose
Drug delivery with BBB opening
Study Objective
To determine whether and how low-intensity focused ultrasound (LiFUS) modulates the blood–brain barrier by involving the purinergic P2X7 receptor, through analysis of molecular, inflammatory, and permeability changes in rat brain tissue.
Animal model / Human subject
Rat (Sprague-Dawley), 7 weeks old, male
Disease model
healthy
MRI or image guidance method
MRI
Targeted brain region(s)
Hippocampus
Target coordinates
AP -3.5 mm (posterior to bregma), ML +2.0 mm (lateral);
Cargo name and characteristics
P2X7 receptor antagonist A430879 ; Evans blue dye ; Gadobutrol
Route of administration
intravenous
Outcomes and Safety
Summary of Outcomes
LiFUS (0.5 MHz transducer with microbubbles at ~0.3 MPa) transiently opened the BBB—peaking at 1 h with increased P2X7 receptor, NLRP3, and IL-1β and decreased tight junction proteins (ZO‑1, occludin) that normalized by 24 h—without detectable tissue damage, and P2X7 receptor antagonism reduced Evans blue leakage.
Duration of biological effect
24 h
Safety-related matter
LiFUS at 0.3 MPa induced a transient inflammatory response (upregulation of P2X7, NLRP3, IL-1β, NF-κB peaking at 1–4 h and normalizing by 24 h) but TUNEL and H&E assays showed no evidence of cell damage or hemorrhage; the authors conclude the procedure is safe under the defined parameters. They nevertheless advise vigilance for potential edema or hemorrhage post-sonication and caution when translating findings to diseased states.
Brain Region
Ultrasound Parameters
Ultrasound instrument
H-107MR, Sonic Concept Inc
FUS Frequency
515 kHz
FUS Intensity
not provided
FUS Pressure
0.3 MPa
FUS Mode
pulsed
Pulse duration
10 ms
Duration of a single FUS session
2 min
Focal Characteristics
51.74 mm
Treatment frequency
single session
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search